August 18, 2016
HEREDITARY BREAST/OVARIAN CANCER: NEW INFORMATION
Last Updated: Aug 18, 2016
- Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial.
Kiechle Marion et al. Trials 2016 17368 - Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers?
Cragun Deborah et al. Genetic testing and molecular biomarkers 2016 Aug - Finding all BRCA pathogenic mutation carriers: best practice models.
Hoogerbrugge Nicoline et al. European journal of human genetics : EJHG 2016 Sep 24 Suppl 1S19-26 - How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
Watts Kaaren J et al. BMC cancer 2012 12320 - Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Wright Alexi A et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Aug - Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT).
Joseph Galen et al. Journal of genetic counseling 2010 Oct 19(5) 447-62 - Stakeholder consultation insights on the future of genomics at the clinical-public health interface.
Modell Stephen M et al. Translational research : the journal of laboratory and clinical medicine 2014 May 163(5) 466-77 - The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.
Trivers Katrina F et al. Healthcare (Basel, Switzerland) 2015 3(4) 948-63 - Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer Risk.
Giordano Sara, et al. Journal of adolescent and young adult oncology 2016 8 - Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer.
Rump Andreas, et al. PLoS genetics 2016 8 (8) e1006248 - A BRCA1/2 mutational signature and survival in ovarian high grade serous carcinoma.
Dong Fei, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 8 - Community attitudes towards a Jewish community BRCA1/2 testing program.
Cousens Nicole et al. Familial cancer 2016 Aug - Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
Meisel Susanne F et al. BMC women's health 2016 16(1) 46 - Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.
Augestad Mirjam Tonheim et al. Journal of genetic counseling 2016 Jul - An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility.
Luo Yi-Qiao, et al. Oncotarget 2016 7
- Human (49)
- Pathogen (0)
- Human (1483)
- Pathogen (0)
- Human (221)
- Pathogen (0)
- Huamn (112)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario